Explorer les evidences

Cervical cancer is a leading cause of cancer death among women of reproductive age.

Kenyacancer du col de l'utéruspublié 2024BMC women's healthPubMeddocument de 3 observations

57 %There was a 57% reduction in rotavirus-associated hospitalizations in the first year post-vaccine introduction in Kilifi.

Kenyarotaviruspublié 2020Clinical infectious diseases : an official publication of the Infectious Diseases Society europe_pmcdocument de 8 observations

45,5 %Among neonates, the prevalence of jaundice was 45.5% in G6PD c.202T heterozygotes.

Kenyajaundicepublié 2020Blood advancesPubMeddocument de 11 observations

11,5 odds_ratioStillbirth was associated with gestational diabetes mellitus (odds ratio 11.5, 95% confidence interval 2.5–52.6).

Kenyadiabète gestationnel · stillbirthobservé August 2018 to April 2019publié 2021International journal of gynaecology and obstetrics: the official organ of the InternationPubMeddocument de 7 observations

2,78 %The prevalence of malaria among blood donations was 2.78%.

Kenyapaludismepublié 2026Global health, epidemiology and genomicsPubMeddocument de 3 observations

1,34 risk_ratioKnowing someone who had cervical cancer was associated with an adjusted risk ratio of 1.34 for screening in Kenya.

Kenyacancer du col de l'utérusobservé 2022-2023publié 2025BMC public healthPubMeddocument de 8 observations

5,04 hazard_ratioPregnancy loss was 5-fold higher among women with moderate-to-severe depressive symptoms (adjusted hazard ratio 5.04, 95% confidence interval 2.44, 10.42).

Kenyamoderate-to-severe depressive symptoms · pregnancy losspublié 2023Paediatric and perinatal epidemiologyPubMeddocument de 8 observations

92,4 %The majority (92.4%) of the RT-PCR positive individuals were asymptomatic in the Coastal part of Kenya between 17th March 2020 and 30th June 2021.

KenyaCOVID-19observé 17th March 2020 to 30th June 2021publié 2022Wellcome open researcheurope_pmcdocument de 10 observations

0,2 %STI prevalence was 0.2% for inguinal bubo syndrome among participants in the African Cohort Study.

KenyaSTIspublié 2021BMC public healthPubMeddocument de 10 observations

0,73 annual_incidence_rate_ratioFor every successive year since 2009, the risk of HIV infection declined with an annual incidence rate ratio of 0.73.

KenyaVIH/sidaobservé 2009publié 2025AIDS and behaviorPubMeddocument de 5 observations

54 foldSeven days after the Ad26.ZEBOV booster, the antibody geometric mean concentration (GMC) increased 54-fold to 38,965 EU/mL.

Kenyamaladie à virus Ebolapublié 2023VaccinePubMeddocument de 2 observations

251 per_100000The HIV/AIDS mortality rate was 251 per 100,000 population.

KenyaVIH/sidaobservé 2019publié 2022PloS onePubMeddocument de 8 observations

45 %The prevalence rate of cisplatin-induced nephrotoxicity in cervical cancer patients was 45%.

Kenyacancer du col de l'utéruspublié 2022Journal of oncology pharmacy practice : official publication of the International Society PubMeddocument de 4 observations

80 %80% of patients assessed for antiretroviral therapy (ART) initiation presented with ≥1 tuberculosis (TB) symptoms.

Kenyatuberculosepublié 2020BMJ openPubMeddocument de 12 observations

60,5 %Among neonates, the prevalence of jaundice was 60.5% in G6PD c.202T homo/hemizygotes.

Kenyajaundicepublié 2020Blood advancesPubMeddocument de 11 observations

12,5 %Each additional year of ART use reduced the likelihood of detection of HR-HPV by 10-15% among Kenyan women living with HIV.

Kenyainfection à HPV · VIH/sidapublié 2021International journal of STD & AIDSPubMeddocument de 5 observations

Short-term forecasting of malaria incidence was performed using state-space reconstruction.

Kenyapaludismepublié 2024Journal of global healthPubMeddocument de 4 observations

The national analysis showed a regional shift in the timelines from the mutant to wild-type crt genotype and similarly from the mutant (CVIET) to wild-type (CVMNK) microhaplotype, with the Coast occurring earlier in 2002, while Western Kenya the change occurred later in 2008.

Kenyapaludismeobservé 2002, 2008publié 2025A scoping review of antimalarial drug resistance markers in Kenya (1987-2022): Toward a Naeurope_pmcdocument de 5 observations

86 %Among 71 treatment-naive men who have sex with men with HIV in the HIV Prevention Trials Network 075 study, 86% sought HIV care following a positive diagnosis.

KenyaVIH/sidaobservé 2015-2017publié 2025AIDS patient care and STDsPubMeddocument de 3 observations

26 %NCD knowledge significantly improved post-training, with mean score increasing from 6.46 to 8.17 (p = 0.0002), representing a 26% increase.

Kenyadiabetes and hypertensionpublié 2026BMC health services researchPubMeddocument de 4 observations

2 850 000 000 inhabitantsIt was estimated that 2.85 billion people were exposed to some risk of Plasmodium vivax transmission in 2009.

Kenyapaludismeobservé 2009publié 2010PLoS neglected tropical diseaseseurope_pmcdocument de 5 observationsDOI 10.1371/journal.pntd.0000774

19,5 %Psychotic symptoms were significantly more prevalent in women (19.5%) compared to men (13.6%) in the study population.

Kenyapsychotic symptomspublié 2019BMC PsychiatryOpenAlexdocument de 9 observationsDOI 10.1186/s12888-019-2118-3

3 monthsThe median time to death was 3 months among patients initiated on antiretroviral therapy in central Kenya.

KenyaVIH/sidapublié 2022BMC infectious diseasesPubMeddocument de 10 observations

44,4 %Mortality at 72 hours was 44.4% for InterceptorG2 in an experimental hut trial against pyrethroid-resistant Anopheles funestus in Siaya, Kenya.

Kenyapaludismepublié 2024Malaria journalPubMeddocument de 5 observations

19,9 %Tobacco use prevalence was 19.9% among males.

Kenyatobacco useobservé 2015publié 2020The Pan African medical journalPubMeddocument de 26 observations